Randomized comparison of two doses of the anti-PD-1 monoclonal antibody MK-3475 for ipilimumab-refractory (IPI-R) and IPI-naive (IPI-N) melanoma (MEL) Meeting Abstract


Authors: Hamid, O.; Robert, C.; Ribas, A.; Wolchok, J. D.; Hodi, F. S.; Kefford, R.; Joshua, A. M.; Hwu, W. J.; Gangadhar, T. C.; Patnaik, A.; Hersey, P.; Weber, J. S.; Joseph, R. W.; Gergich, K.; Li, X. Y.; Chun, P.; Ebbinghaus, S.; Kang, S. P.; Daud, A.
Abstract Title: Randomized comparison of two doses of the anti-PD-1 monoclonal antibody MK-3475 for ipilimumab-refractory (IPI-R) and IPI-naive (IPI-N) melanoma (MEL)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202892
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.3000
Notes: Meeting Abstract: 3000 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok